Logo - springer
Slogan - springer

Medicine - Cardiology & Angiology | Pulmonary Hypertension

Pulmonary Hypertension

Hill, Nicholas S., Farber, Harrison W.

2008, XV, 444 p.

A product of Humana Press
Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$209.00

(net) price for USA

ISBN 978-1-60327-075-5

digitally watermarked, no DRM

Included Format: PDF

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$269.00

(net) price for USA

ISBN 978-1-58829-661-0

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$269.00

(net) price for USA

ISBN 978-1-61737-702-0

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

  • Pathophysiology and therapy of pulmonary hypertension have had enormous developments over the past decade
  • Discoveries of endothelin excess as well as prostacyclin and nitric oxide deficiency have led to important therapeutic insights
  • Identification of genes associated with pulmonary hypertension has begun to open the door to pathophysiologic insights
  • Expert authors describe new therapies that have led to significant improvements in patient function, quality of life, and survival

This timely volume addresses the areas of pathophysiology and therapy of pulmonary hypertension, which have seen exciting developments over the past decade. The discoveries of endothelin overexpression as well as prostacyclin and nitric oxide deficiency in association with pulmonary hypertension have led to important therapeutic insights. In addition, the identification of genes associated with pulmonary hypertension has just begun to open the door to new pathophysiologic insights. The new therapies have led to significant improvements in patient function, quality of life and survival.

This book will be of interest not only to cardiologists, pulmonary specialists and rheumatologists, but also many nurses and pharmacotherapists are becoming increasingly involved in the therapy of patients with pulmonary hypertension.

Content Level » Professional/practitioner

Keywords » Atmen - HIV - hypertension - pathophysiology - physiology - transplantation

Related subjects » Cardiology & Angiology - Internal Medicine - Rheumatology

Table of contents 

Chapter 1. Historical Perspective: A Century of Primary (Idiopathic) Pulmonary Hypertension. Alfred P. Fishman MD Chapter 2: Classification of Pulmonary Hypertension C. William Hargett, MD and Victor F. Tapson, MD (2 Tables) Chapter 3. Diagnostic Approach to Pulmonary Arterial Hypertension (1 figure) Ronald J. Oudiz, MD, FACP, FACC Chapter 4. Pathophysiology of Pulmonary Arterial Hypertension Harrison W. Farber, M.D. Chapter 5: Pulmonary Hypertension Genes (Check references) Elisabeth Donlevy Willers, MD and Ivan M. Robbins, MD Chapter 6. The Right Ventricle in Pulmonary Hypertension Andrew C. Stone, MD and James R. Klinger, MD Chapter 7. Congenital Heart Disease Associated Pulmonary Arterial Hypertension Michael J. Landzberg, MD Chapter 8. Connective Tissue Disease Associated Pulmonary Hypertension Kimberly Fisher, MD, Nicholas S. Hill, MD and Harrison Farber, MD Chapter 9. Pulmonary Hypertension associated with HIV, Liver Disease, Sarcoidosis and Sickle Cell Disease. Kimberly A. Fisher, MD and Elizabeth S. Klings, MD Chapter 10. Chronic Thromboembolic Pulmonary Hypertension Victor J. Test, MD, William R. Auger, MD and Peter F. Fedullo, MD. Chapter 11. General Therapeutic Approach and Traditional Therapies Nicholas S. Hill, MD and Elizabeth Klings, MD Chapter 12. Prostacyclin Therapy for Pulmonary Arterial Hypertension Nicholas S. Hill MD, Todd F. Vardas, MD and Vallerie McLaughlin MD Chapter 13. Endothelin and its blockade in pulmonary arterial hypertension David Langleben, MD, FRCPC Chapter 14. PDE 5 Inhibitors and the cGMP Pathway in Pulmonary Arterial Hypertension Ioana R. Preston MD Chapter 15. Statins for treatment of pulmonary hypertension John L. Faul MD, Peter N. Kao MD, Toshihiko Nishimura MD, Arthur Sung MD, Hong Hu MD and Ronald G. Pearl MD, PhD Chapter 16. Transitions and Combination Therapy for Pulmonary Arterial Hypertension Todd Hirschtritt MD, M. Kathryn Steiner MD and Nicholas S. Hill MD Chapter 17. Acute right ventricular dysfunction: focus on acute cor pulmonale Antoine Vieillard-Baron MD, Fran├žois Jardin MD Chapter 18. Lung transplantion and atrial septostomy for pulmonary arterial hypertension E.P. Trulock MD Chapter 19 : New Directions in Pulmonary Hypertension Therapy Christopher M Carlin BSc (Hons) MB ChB (Hons) MRCP Andrew J Peacock MD FRCP

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Cardiology.